This inventor holds 1 USPTO granted patent. Top assignee: Columbia University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Andrew Beenken: Innovator in Acute Kidney Injury Treatment
Introduction
Andrew Beenken is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of Acute Kidney Injury (AKI). His innovative approach focuses on the reactivation of mTOR, a critical pathway in cellular regulation.
Latest Patents
Andrew Beenken holds 1 patent for his work titled "Reactivation of mTOR in Acute Kidney Injury (AKI)." This patent describes a method for treating, preventing, or reducing the incidence of AKI by administering a pharmaceutically effective amount of one or more amino acids to individuals in need.
Career Highlights
Beenken is affiliated with Columbia University, where he continues to advance research in kidney health. His work has garnered attention for its potential to improve patient outcomes in those suffering from AKI.
Collaborations
He collaborates with esteemed colleagues, including Andong Qiu and Jonathan Barasch, to further explore innovative solutions in the medical field.
Conclusion
Andrew Beenken's contributions to the treatment of Acute Kidney Injury highlight his role as a leading inventor in medical innovation. His work promises to enhance the understanding and management of kidney health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile